Trinity Biotech Announces CE Mark of its 10-Minute Covid-19 Antigen Test
Morningstar· 13 hours agoIn addition to its ease-of-use and impressive speed to result, in extensive clinical trails the test has demonstrated excellent 99% sensitivity and 99% ...
Cepheid Gets CE Mark for Updated Rapid COVID MDx Test
GenomeWeb News· 1 day agoCepheid announced on Thursday that it has obtained the CE mark for a rapid molecular test to detect the SARS-CoV-2 virus. Called Xpert Xpress CoV-2 plus ...
Rapid virus test developed using gold particles along with lasers
Colorado Springs Gazette· 2 weeks agoUniversity of Texas at Dallas researchers have developed a rapid virus test using gold particles and lasers that promises to deliver results as accurate ...
Therma Bright to Submit Application to Health Canada for Approval of its AcuVid(TM) COVID-19 Rapid...
Associated Press· 1 week agoFood & Drug Administration (FDA) for review of its AcuVid™ COVID-19 Rapid Antigen Saliva Test on March 29, 2022.
Cepheid Adds New Gene Target to SARS-CoV-2 Molecular Test to Account for Variants
GenomeWeb News· 1 week agoDanaher subsidiary Cepheid announced on Thursday that its Xpert Xpress CoV-2 plus test has received Emergency Use Authorization from the US Food and Drug ...
Neogen® Launches Enhanced Quantitative Peanut ELISA Assay
Valley News Live· 3 days agoNeogen's new...Improvement Platform) for Peanut assay is able to rapidly quantify low levels of peanut protein residues in food products, ingredients, and clean-in-place rinses ...
Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria® Bladder...
Hawaii News Now· 1 week agoMINNEAPOLIS and LOS ANGELES, May 12, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and Nonagen Bioscience today announced an agreement for R&D Systems, a Bio-Techne brand, to exclusively manufacture Nonagen Bioscience's Oncuria® bladder
Cepheid Receives Emergency Use Authorization for Xpert® Xpress CoV-2 plus
Hawaii News Now· 1 week agoNew "plus" version of test adds a 3rd gene target to enhance detection of future SARS-CoV-2 variantsSUNNYVALE, Calif., May 12, 2022 /PRNewswire/ -- Cepheid today announced ...
Lucira Health, Inc. (LHDX) Q1 2022 Earnings Call Transcript
Motley Fool· 1 week agoEarlier today, Lucira Health released financial results for the first quarter ended March 31, 2022....
Rapid evolution of an adaptive taste polymorphism disrupts courtship behavior - Communications...
Nature· 1 week agoA study of German cockroaches with glucose-aversion reveals how this adaptation to avoid glucose-containing insecticides causes females to reject courting males, because their salivary enzymes degrade sugars in the male’s nuptial gift into glucose.
Yahoo Web Search
Trending Now
